ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.909,14
-0,25%
S&P 500
5.881,63
-0,43%
Dow Jones
42.544,22
-0,07%
Euro vs US Dollar
1,03718
0,20%
Bitcoin
94.885,58
0,52%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Coeptis Therapeutics Holdings Inc (COEP)

  7. Coeptis Therapeutics Holdings Inc (COEP) News

COEP

Coeptis Therapeutics (COEP)

Coeptis Therapeutics Holdings Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:COEP
DatumZeitQuelleÜberschriftSymbolFirma
31/12/202420h20AllPennyStocks.comTrading Halt Occurred During This Micro Cap's EOY SurgeNASDAQ:COEPCoeptis Therapeutics Holdings Inc
27/12/202414h15PR Newswire (US)Coeptis Therapeutics Announces Reverse Stock SplitNASDAQ:COEPCoeptis Therapeutics Holdings Inc
26/12/202414h15PR Newswire (US)Coeptis Therapeutics Makes Bold Strides in Innovation with the Acquisition of NexGenAI Affiliates Network Platform and Launch of Coeptis TechnologiesNASDAQ:COEPCoeptis Therapeutics Holdings Inc
12/12/202414h00PR Newswire (US)Coeptis Therapeutics Unveils New Technology Division: Coeptis TechnologiesNASDAQ:COEPCoeptis Therapeutics Holdings Inc
03/12/202414h15PR Newswire (US)Coeptis Therapeutics Executes Binding Letter of Intent to Acquire Ai-powered Marketing Solutions for Biotech, Pharmaceutical and Other IndustriesNASDAQ:COEPCoeptis Therapeutics Holdings Inc
07/11/202414h07PR Newswire (US)Coeptis Therapeutics Announces Phase 1 Data on DVX201 for COVID-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical DevelopmentNASDAQ:COEPCoeptis Therapeutics Holdings Inc
24/10/202414h07PR Newswire (US)Coeptis Therapeutics Expands License Agreement with Deverra to Include Pandemic Preparedness, and Emergency UseNASDAQ:COEPCoeptis Therapeutics Holdings Inc
15/10/202414h07PR Newswire (US)Coeptis Therapeutics' Chief Scientific and Medical Officer to Present at Upcoming Fall Conferences, Highlighting Progress in Universal Cell TherapyNASDAQ:COEPCoeptis Therapeutics Holdings Inc
19/09/202413h07PR Newswire (US)Coeptis Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued ListingNASDAQ:COEPCoeptis Therapeutics Holdings Inc
05/09/202414h07PR Newswire (US)Coeptis Therapeutics Chief Executive Officer, Dave Mehalick, Updates and Outlines Strategic Vision in Letter to ShareholdersNASDAQ:COEPCoeptis Therapeutics Holdings Inc
16/08/202422h02Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:COEPCoeptis Therapeutics Holdings Inc
16/08/202422h01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:COEPCoeptis Therapeutics Holdings Inc
14/08/202423h26Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:COEPCoeptis Therapeutics Holdings Inc
14/08/202423h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:COEPCoeptis Therapeutics Holdings Inc
31/07/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:COEPCoeptis Therapeutics Holdings Inc
20/06/202414h47PR Newswire (US)Coeptis Therapeutics Closes on $4.3 Million of Series A Preferred OfferingNASDAQ:COEPCoeptis Therapeutics Holdings Inc
30/05/202414h47PR Newswire (US)Coeptis Therapeutics' Dr. Colleen Delaney to Present at Allogeneic Cell Therapies Summit 6th Annual MeetingNASDAQ:COEPCoeptis Therapeutics Holdings Inc
08/05/202414h47PR Newswire (US)Coeptis Therapeutics to Present its Universal Allogeneic SNAP-CAR NK Cell Therapy at the ISCT 2024NASDAQ:COEPCoeptis Therapeutics Holdings Inc
02/05/202414h47PR Newswire (US)Coeptis Therapeutics Announces Poster Data Presentation at American Society of Gene & Cell Therapy (ASGCT) 27th Annual MeetingNASDAQ:COEPCoeptis Therapeutics Holdings Inc
02/04/202414h47PR Newswire (US)Coeptis Therapeutics Congratulates Alexander Deiters, Professor at the University of Pittsburgh, on Receiving the 2024 Chancellor's Distinguished Research AwardNASDAQ:COEPCoeptis Therapeutics Holdings Inc
26/02/202415h00PR Newswire (US)Coeptis Therapeutics Adds Autoimmune Indications to Exclusive License Agreement with University of Pittsburgh for SNAP-CAR T and SNAP-CAR NKNASDAQ:COEPCoeptis Therapeutics Holdings Inc
07/02/202413h30PR Newswire (US)Coeptis Therapeutics to Pursue Phase 2 Program Using Proprietary First-in-Class Allogeneic NK Cell Therapy for the Treatment of Viral InfectionsNASDAQ:COEPCoeptis Therapeutics Holdings Inc
04/01/202413h30PR Newswire (US)Coeptis Therapeutics President and CEO Issues Letter to Shareholders Highlighting 2023 Accomplishments and Outlook for 2024NASDAQ:COEPCoeptis Therapeutics Holdings Inc
31/10/202314h01PR Newswire (US)Coeptis Therapeutics Announces Research Demonstrating the Potential of SNAP-CAR T-cells to Reduce Tumor Burden and Growth in HER2 and CD20 Expressing Cancers Will be Presented at SITC 2023NASDAQ:COEPCoeptis Therapeutics Holdings Inc
24/10/202314h30PR Newswire (US)Coeptis Therapeutics Announces $2 Million Private PlacementNASDAQ:COEPCoeptis Therapeutics Holdings Inc
11/10/202313h30PR Newswire (US)Coeptis Therapeutics Expands License Agreement with University of Pittsburgh to Include SNAP-CAR NK Cell TechnologyNASDAQ:COEPCoeptis Therapeutics Holdings Inc
09/10/202315h15PR Newswire (US)Coeptis Therapeutics to Participate in Panel at the BioFlorida Conference Discussing Emerging Cell and Gene TherapiesNASDAQ:COEPCoeptis Therapeutics Holdings Inc
04/10/202313h30PR Newswire (US)Coeptis Therapeutics Announces Research Involving SNAP-CAR Accepted for Presentation at the Society for Immunotherapy of Cancer's 38th Annual MeetingNASDAQ:COEPCoeptis Therapeutics Holdings Inc
27/09/202313h30PR Newswire (US)Coeptis Therapeutics to Present at the 2023 Cell & Gene Meeting on the MesaNASDAQ:COEPCoeptis Therapeutics Holdings Inc
14/09/202313h30PR Newswire (US)Coeptis Therapeutics Provides Safety and Dosing Update from Phase 1 Trials Investigating DVX201 in Relapsed/Refractory AML or High Risk MDS and Hospitalized COVID-19 InfectionNASDAQ:COEPCoeptis Therapeutics Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:COEP

Kürzlich von Ihnen besucht

DBI
SDXP
SDAX
NYSE
JPM
JP Morgan Chase
NASDAQ
AAPL
Apple
PM
XAUUSD
Gold vs US Dollar
USOTC
BASFY
BASF (QX)
FX
EURGBP
Euro vs Sterling
COIN
SOLUSD
Solana
COIN
ETHUSD
Ethereum
AMEX
XLF
Financial Select Sector
NASDAQ
TSLA
Tesla
NASDAQ
MSFT
Microsoft
USOTC
BNPQY
BNP Paribas (QX)
TG
TUI1
Tui
USOTC
ADDYY
Adidas (QX)
NYSE
DIS
Walt Disney
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten